These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15932334)

  • 1. Improved solution- and solid-phase preparation of hydroxamic acids from esters.
    Ho CY; Strobel E; Ralbovsky J; Galemmo RA
    J Org Chem; 2005 Jun; 70(12):4873-5. PubMed ID: 15932334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient continuous flow synthesis of hydroxamic acids and suberoylanilide hydroxamic acid preparation.
    Riva E; Gagliardi S; Mazzoni C; Passarella D; Rencurosi A; Vigo D; Martinelli M
    J Org Chem; 2009 May; 74(9):3540-3. PubMed ID: 19351173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High stability and high efficiency chemiluminescent acridinium compounds obtained from 9-acridine carboxylic esters of hydroxamic and sulphohydroxamic acids.
    Renotte R; Sarlet G; Thunus L; Lejeune R
    Luminescence; 2000; 15(5):311-20. PubMed ID: 11038489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diversity of hydroxamic acids: part I. Solution- and solid-phase synthesis.
    Yang K; Lou B
    Mini Rev Med Chem; 2003 Jun; 3(4):349-60. PubMed ID: 12678828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase synthesis of N-formylhydroxylamines (reverse/retro-hydroxamates).
    Price S; Osbourn SE
    Org Lett; 2005 Aug; 7(17):3761-3. PubMed ID: 16092869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general strategy for the synthesis of cyclic N-aryl hydroxamic acids via partial nitro group reduction.
    McAllister LA; Bechle BM; Dounay AB; Evrard E; Gan X; Ghosh S; Kim JY; Parikh VD; Tuttle JB; Verhoest PR
    J Org Chem; 2011 May; 76(9):3484-97. PubMed ID: 21452845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of succinylhydroxamate peptides: functionalized matrix metalloproteinase inhibitors.
    Leeuwenburgh MA; Geurink PP; Klein T; Kauffman HF; van der Marel GA; Bischoff R; Overkleeft HS
    Org Lett; 2006 Apr; 8(8):1705-8. PubMed ID: 16597146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angeli-Rimini's reaction on solid support: a new approach to hydroxamic acids.
    Porcheddu A; Giacomelli G
    J Org Chem; 2006 Sep; 71(18):7057-9. PubMed ID: 16930063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase synthesis of biologically interesting compounds containing hydroxamic acid moiety.
    Krchnák V
    Mini Rev Med Chem; 2006 Jan; 6(1):27-36. PubMed ID: 16457630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-heterocyclic carbene (NHC)-catalyzed direct amidation of aldehydes with nitroso compounds.
    Wong FT; Patra PK; Seayad J; Zhang Y; Ying JY
    Org Lett; 2008 Jun; 10(12):2333-6. PubMed ID: 18476704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step synthesis of O-benzyl hydroxamates from unactivated aliphatic and aromatic esters.
    Gissot A; Volonterio A; Zanda M
    J Org Chem; 2005 Aug; 70(17):6925-8. PubMed ID: 16095317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple one-flask method for the preparation of hydroxamic acids.
    Giacomelli G; Porcheddu A; Salaris M
    Org Lett; 2003 Jul; 5(15):2715-7. PubMed ID: 12868897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the FEZ-1 metallo-beta-lactamase.
    Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
    Flipo M; Beghyn T; Charton J; Leroux VA; Deprez BP; Deprez-Poulain RF
    Bioorg Med Chem; 2007 Jan; 15(1):63-76. PubMed ID: 17070058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for the solution-phase parallel synthesis of N-(pyrrolidinylmethyl)hydroxamic acids.
    Takayanagi M; Flessner T; Wong CH
    J Org Chem; 2000 Jun; 65(12):3811-5. PubMed ID: 10864769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis.
    Biron E; Kessler H
    J Org Chem; 2005 Jun; 70(13):5183-9. PubMed ID: 15960522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-supported acids for debenzylation of aryl benzyl ethers.
    Petchmanee T; Ploypradith P; Ruchirawat S
    J Org Chem; 2006 Mar; 71(7):2892-5. PubMed ID: 16555850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentiometric determination of Hg2+ - and Cu2+ - ions with oxalodihydroxamin acid (author's transl)].
    Przyborowski L; Smajkiewicz A
    Ann Univ Mariae Curie Sklodowska Med; 1974; 29():309-16. PubMed ID: 4467811
    [No Abstract]   [Full Text] [Related]  

  • 19. Modeling the inhibition of peptide deformylase by hydroxamic acids: influence of the sulfur donor.
    Galardon E; Giorgi M; Artaud I
    Dalton Trans; 2007 Mar; (10):1047-52. PubMed ID: 17325780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase).
    Warmus JS; Flamme C; Zhang LY; Barrett S; Bridges A; Chen H; Gowan R; Kaufman M; Sebolt-Leopold J; Leopold W; Merriman R; Ohren J; Pavlovsky A; Przybranowski S; Tecle H; Valik H; Whitehead C; Zhang E
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6171-4. PubMed ID: 18951019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.